Diabetes mellitus type 2 group I Atherosclerosis group II control group significance A B C D Creatinine [mg/dl] 1.1 ± 0.3 1.0 ± 0.2 1.1 ± 0.2 1.2 ± 0.4 0.9 ± 0.1 A vs. C; NS B vs. D; NS A vs. contr.; p<0.001 B vs. contr.; NS C vs. contr.; p<0.005 D vs. contr.; p<0.05 uric acid [mg/dl] 5.1 ± 1.3 4.2 ± 1.0 5.2 ± 1.2 4.5 ± 1.2 4.0 ± 1.4 A vs. C; NS B vs. D; NS A vs. contr.; p<0.001 B vs. contr.; NS C vs. contr.; p<0.01 D vs. contr.; NS total cholesterol [mg/dl] 217.4 ± 49.0 180.3 ± 49.0 229.4 ± 43.3 205.2 ± 47.2 189.4 ± 25.4 A vs. C; NS B vs. D; NS A vs. contr.; p<0.05 B vs. contr.; NS C vs. contr.; p<0.001 D vs. contr.; NS LDL cholesterol [mg%] 118.8 ± 43.5 85.9 ± 31.8 148.1 ± 43.8 119.6 ± 41.7 102.8 ± 25.3 A vs. C; p<0.01 B vs. D; p<0.05 A vs. contr.; NS B vs. contr.; NS C vs. contr.; p<0.001 D vs. contr.; NS HDL cholesterol [mg/dl] 48.4 ± 12.3 46.1 ± 11.7 46.4 ± 11.7 54.2 ± 17.2 67.2 ± 14.1 A vs. C; NS B vs. D; NS A vs. contr.; p<0.001 B vs. contr.; p<0.001 C vs. contr.; p<0.001 D vs. contr.; p<0.01 triglycerides [mg/dl] 293.1 ± 235.5 217.5 ± 20.4 173.1 ± 74.1 167.8 ± 91.4 97.2 ± 39.3 A vs. C; p<0.01 B vs. D; NS A vs. contr.; p<0.001 B vs. contr.; p<0.001 C vs. contr.; p<0.001 D vs. contr.; p<0.01 Results are expressed as mean ± standard deviation. NS: Not Statistically Significant

Table 2: Selected laboratory parameters of the analyzed groups.